These findings raise the intriguing possibility that targeting bile acid metabolic pathways and/or bile acid receptor signaling to reduce the levels of specific bile acids and the accumulation of secondary bile acids as well as inhibiting the activation of detrimental signaling pathways may be a beneficial treatment strategy for gastric cancer prevention. Here, NR1H4 is linked to gastric cancer.